The Emergence of the Asian Xenotransplantation Association: Regional Collaboration in a Rapidly Evolving Field

Global progress in xenotransplantation has accelerated following recent first‐in‐human applications of gene‐edited porcine organs. While pioneering clinical experiences have largely been reported from the United States, scientific, translational, and early clinical activities are also expanding across Asia, particularly in China. In this context, regional coordination and sustained dialogue are increasingly important. The establishment of the Asian Xenotransplantation Association (AXA) represents a collaborative initiative to strengthen scientific exchange and foster cooperation among investigators in China, Korea, Japan, India, and the broader Asian community. The first AXA Congress, held in Haikou, China, in December 2025, marked the formal launch of this effort. With the second AXA Congress scheduled for August 24–25, 2026 in Chengdu, China, AXA aims to continue promoting communication, harmonization of research approaches, and the development of the next generation of investigators. Through inclusive and responsible collaboration, AXA seeks to contribute constructively to the global advancement of xenotransplantation.